[go: up one dir, main page]

NO20001415L - Farmasøytikum inneholdende vitamin-K-avhengige faktorer - Google Patents

Farmasøytikum inneholdende vitamin-K-avhengige faktorer

Info

Publication number
NO20001415L
NO20001415L NO20001415A NO20001415A NO20001415L NO 20001415 L NO20001415 L NO 20001415L NO 20001415 A NO20001415 A NO 20001415A NO 20001415 A NO20001415 A NO 20001415A NO 20001415 L NO20001415 L NO 20001415L
Authority
NO
Norway
Prior art keywords
containing vitamin
pharmaceuticals containing
dependent factors
dependent
factors
Prior art date
Application number
NO20001415A
Other languages
English (en)
Other versions
NO20001415D0 (no
Inventor
Yendra Linnau
Peter Turecek
Hans-Peter Schwarz
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of NO20001415D0 publication Critical patent/NO20001415D0/no
Publication of NO20001415L publication Critical patent/NO20001415L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Et farmasøytisk separert protrombinkomplekspreparat som inneholder minst 2 høytrensede vitamin K-avhengige enkelt- blodfaktorer.
NO20001415A 1997-09-19 2000-03-17 Farmasøytikum inneholdende vitamin-K-avhengige faktorer NO20001415L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0159197A AT409334B (de) 1997-09-19 1997-09-19 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
PCT/AT1998/000224 WO1999015196A1 (de) 1997-09-19 1998-09-17 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren

Publications (2)

Publication Number Publication Date
NO20001415D0 NO20001415D0 (no) 2000-03-17
NO20001415L true NO20001415L (no) 2000-05-19

Family

ID=3516739

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001415A NO20001415L (no) 1997-09-19 2000-03-17 Farmasøytikum inneholdende vitamin-K-avhengige faktorer

Country Status (10)

Country Link
EP (1) EP1015020A1 (no)
JP (1) JP2001517636A (no)
AT (1) AT409334B (no)
AU (1) AU743102B2 (no)
BR (1) BR9812222A (no)
CA (1) CA2304396A1 (no)
HU (1) HUP0003681A1 (no)
NO (1) NO20001415L (no)
SK (1) SK4022000A3 (no)
WO (1) WO1999015196A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005530683A (ja) 2001-12-21 2005-10-13 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 第ｖｉｉ因子ポリペプチドの液体組成物
AU2003213146A1 (en) * 2002-03-08 2003-09-22 Eli Lilly And Company Activated protein c formulations
CN101912601B (zh) 2002-06-21 2012-08-29 诺和诺德医疗保健公司 因子vii多肽的稳定化固体组合物
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
CA2525224A1 (en) 2003-05-23 2004-12-02 Michael Bech Jensen Protein stabilization in solution
ATE547114T1 (de) 2003-06-25 2012-03-15 Novo Nordisk Healthcare Ag Flüssige zusammensetzungen von factor vii polypeptiden
CN1845753A (zh) 2003-08-14 2006-10-11 诺和诺德医疗保健公司 因子ⅶ多肽类的含水液体药物组合物
DK2298287T3 (en) 2003-12-19 2018-07-23 Novo Nordisk Healthcare Ag Stabilized compositions of factor VII polypeptides
JP2008530208A (ja) * 2005-02-16 2008-08-07 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 万能前凝固薬
CN101184775A (zh) 2005-03-04 2008-05-21 伊利诺斯大学理事会 凝血及纤溶级联系统的调控剂
US8821861B2 (en) 2007-10-05 2014-09-02 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2009061697A1 (en) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Anticoagulant antagonist and hemophilia procoagulant
SG10201407983VA (en) 2009-12-18 2015-01-29 Csl Ltd Method of purifying polypeptides
BR112013008034A2 (pt) 2010-10-06 2016-06-14 Medimmune Ltd método para normalizar hemeostase comprometida
US11744880B2 (en) * 2017-02-09 2023-09-05 Csl Behring Gmbh Blood coagulation factor replacement product for use in the treatment or prophylaxis of bleedings

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
ATE296109T1 (de) * 1996-03-20 2005-06-15 Baxter Ag Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen

Also Published As

Publication number Publication date
BR9812222A (pt) 2000-07-18
AU9244998A (en) 1999-04-12
AT409334B (de) 2002-07-25
AU743102B2 (en) 2002-01-17
ATA159197A (de) 2001-12-15
WO1999015196A1 (de) 1999-04-01
HUP0003681A1 (hu) 2001-02-28
SK4022000A3 (en) 2000-09-12
EP1015020A1 (de) 2000-07-05
NO20001415D0 (no) 2000-03-17
CA2304396A1 (en) 1999-04-01
JP2001517636A (ja) 2001-10-09

Similar Documents

Publication Publication Date Title
NO20001415L (no) Farmasøytikum inneholdende vitamin-K-avhengige faktorer
CO5060503A1 (es) Formulaciones farmaceuticas
PT83872A (de) Arzneimittel
DZ1966A1 (fr) Combinaison pharmaceutique nouvelle.
ATE304351T1 (de) Arzneizubereitungen enthaltend kannabinoide
FI881660A7 (fi) Foerfarande och anordning foer separering av gas med pumpen ur mediet som skall pumpas.
NO307459B1 (no) Piperazinderivater, samt farmasøytiske preparater inneholdende slike
FI853913A0 (fi) Farmaceutiska foereningar som antracyklinglykosider.
NO901657L (no) Fuktende baeremiddel for topisk administrering av vitamin a syre.
FI861532A0 (fi) Foerfarande foer att insamla uppgifter som en brand, branddetektor som utnyttjar detta foerfarande och brandalarmsystem som likasao utnyttjar detta foerfarande.
FI893095A7 (fi) Foerfarande foer infoerande och bindande av gas i vatten, anordning foer utfoerande av foerfarandet och vatten som framstaellts med foerfarandet.
YU52999A (sh) Kombinacija analgetika
FI954986L (fi) Uudet, suun kautta annettavat, syklosporiinia sisältävät farmaseuttiset valmisteet
FI963251L (fi) Farmaseuttinen valmiste, jossa on plasminogeeniaktivaattoreita
ES2193539T3 (es) Benzonaftiridinas.
AU8910698A (en) Alkali metal hybrid spin-exchange optical pumping
FI891865L (fi) Laekemedel som innehaoller azelastin med kontrollerad frigoering av det verksamma aemnet.
FI870663A7 (fi) Fettemulsioner, som innehaoller prostaglandin i 2.
ES2109103T3 (es) Procedimiento para la preparacion de trialquilsilil-7 bacatina iii.
MX9603606A (es) N-metil-n-[(1s)-1-fenil-2-((3s)-3-hidroxipirrolidin-1-il) etil]-2,2-difenil-acetamida.
FI884545A0 (fi) Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar.
FI905640L (fi) Foerfarande foer blekning av traemassa med basisk peroxid med anvaendande av kvaternaer amin som tillsatsaemne.
IT1191255B (it) Composizione farmaceutiche a base di alcaloidi della segale cornuta 9,10-diidrogenati
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
FI883912A0 (fi) Centrifugalpumphjul och saett vid pumpning av en vaetska, som innehaoller gas, medelst en centrifugalpump.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application